Growth Metrics

DBV Technologies (DBVT) Other Accumulated Expenses (2014 - 2026)

DBV Technologies (DBVT) reported Other Accumulated Expenses of $10.8 million for Q1 2026, up 98.27% year-over-year from $5.4 million in Q1 2025, and down 31.65% on a QoQ basis from $15.8 million in Q4 2025.

DBV Technologies (DBVT) has 13 years of Other Accumulated Expenses data on file, last reported at $10.8 million in Q1 2026.

  • Quarterly Other Accumulated Expenses rose 98.27% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (up 98.27% YoY) and the FY2025 annual result came in at $15.8 million, up 89.72% from the prior year.
  • Other Accumulated Expenses declined to $10.8 million in Q1 2026 per DBVT's latest filing, from $15.8 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $15.8 million in Q4 2025 and bottomed at $5.0 million in Q1 2024.
  • The 5-year median for Other Accumulated Expenses is $8.4 million (2025), against an average of $8.4 million.
  • The widest annual swing landed in 2022, when Other Accumulated Expenses tumbled 34.9%; it then jumped 98.27% in 2026.
  • Tracing DBVT's Other Accumulated Expenses over 5 years: stood at $9.2 million in 2022, then fell by 3.0% to $8.9 million in 2023, then fell by 6.78% to $8.3 million in 2024, then surged by 89.72% to $15.8 million in 2025, then tumbled by 31.65% to $10.8 million in 2026.
  • Per Business Quant, the three latest DBVT Other Accumulated Expenses figures stand at $10.8 million (Q1 2026), $15.8 million (Q4 2025), and $8.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.80 Mn
Dec 31, 2025 15.80 Mn
Sep 30, 2025 8.45 Mn
Jun 30, 2025 7.52 Mn
Mar 31, 2025 5.45 Mn
Dec 31, 2024 8.33 Mn
Sep 30, 2024 7.79 Mn
Jun 30, 2024 6.16 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 8.93 Mn
Sep 30, 2023 8.67 Mn
Jun 30, 2023 7.26 Mn
Mar 31, 2023 6.78 Mn
Dec 31, 2022 9.21 Mn
Sep 30, 2022 8.62 Mn
Jun 30, 2022 8.78 Mn
Mar 31, 2022 8.72 Mn
Dec 31, 2021 12.36 Mn
Sep 30, 2021 12.66 Mn
Jun 30, 2021 12.67 Mn
Mar 31, 2021 13.39 Mn
Dec 31, 2020 22.93 Mn
Jun 30, 2020 18.85 Mn
Dec 31, 2019 24.57 Mn
Sep 30, 2019 1.27 Mn
Jun 30, 2019 21.53 Mn
Dec 31, 2018 14.27 Mn
Sep 30, 2018 2.37 Mn
Jun 30, 2018 13.39 Mn
Dec 31, 2017 18.55 Mn
Jun 30, 2017 18.16 Mn
Dec 31, 2016 15.86 Mn
Jun 30, 2016 13.06 Mn
Dec 31, 2015 6.40 Mn
Jun 30, 2015 3.22 Mn
Dec 31, 2014 4.29 Mn